Free Trial

DIAGNOS Q2 2025 Earnings Report

DIAGNOS logo
$0.24 +0.00 (+1.20%)
As of 01/21/2025 02:10 PM Eastern

DIAGNOS EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

DIAGNOS Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

DIAGNOS Announcement Details

Quarter
Q2 2025
Time
During Market Hours

Conference Call Resources

DIAGNOS Earnings Headlines

DIAGNOS Announces the Engagement of Promoter
Open Thread: November 8, 2024
Elon Musk: my AI will be “worth more than Tesla”
Tesla made Elon Musk the richest man in human history. And now, Elon's got a new AI project...
NGMDF NuGen Medical Devices Inc.
DIAGNOS Announces Closing of Private Placement
See More DIAGNOS Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DIAGNOS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DIAGNOS and other key companies, straight to your email.

About DIAGNOS

DIAGNOS (OTCMKTS:DGNOF) provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

View DIAGNOS Profile

More Earnings Resources from MarketBeat